As per MRFR analysis, the US IVD Contract Manufacturing Market Size was estimated at 1.74 (USD Billion) in 2023. The US IVD Contract Manufacturing Market is expected to grow from 1.95 (USD Billion) in 2024 to 3.49 (USD Billion) by 2035. The US IVD Contract Manufacturing Market CAGR (growth rate) is expected to be around 5.411% during the forecast period (2025 - 2035).
Key US IVD Contract Manufacturing Market Trends Highlighted
The growing need for personalised medicine, regulatory changes, and technological improvements are driving a number of significant trends in the US IVD (In Vitro Diagnostic) Contract Manufacturing Market. The increasing focus on diagnostics as vital instruments for illness management and prevention, especially in light of the COVID-19 pandemic, is one major market driver.
As a result, there is now a strong ecosystem for IVD producers, with both the public and commercial sectors investing more in research and development. Furthermore, contract manufacturers must adjust to meet the growing demand for more advanced diagnostic tests due to the increased incidence of chronic diseases in the US.
Utilising automation and digital technology to increase manufacturing efficiency and shorten the time to market for novel diagnostic tests is one of the market's opportunities. Contract manufacturers can benefit from the need for compliance in product development and quality assurance procedures as regulatory agencies such as the FDA continue to update their rules for medical devices.
There is also a big chance to improve quality control and expedite processes by using artificial intelligence and data analytics into manufacturing processes. There has been a noticeable shift in recent years towards cooperation and partnerships between US academic institutions, biotech businesses, and IVD producers.
Smaller businesses with cutting-edge technology can launch their solutions faster thanks to this cooperative strategy, which also helps to speed up product development. Additionally, because keeping in-house production facilities is expensive, there is a shift towards outsourcing manufacturing skills.
Stakeholders in the US IVD Contract Manufacturing Market can strategically position themselves to meet changing client needs and spur growth in a competitive market by concentrating on these developing trends.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
US IVD Contract Manufacturing Market Drivers
Increasing Demand for Point-of-Care Testing
The US IVD Contract Manufacturing Market is driven by the rising demand for point-of-care testing (POCT), which has significantly accelerated due to the need for rapid diagnostic solutions. According to the Centers for Disease Control and Prevention (CDC), point-of-care testing has seen an increase in adoption, particularly during the COVID-19 pandemic, where it was essential for immediate diagnostic results.
This considerable shift in testing methods signifies a growing preference, with the market for POCT estimated to reach substantial figures, highlighting an upward trend.
Prominent companies such as Abbott Laboratories and Roche Diagnostics are focusing heavily on the development and manufacture of advanced point-of-care diagnostics, thereby contributing to overall growth in the contract manufacturing sector within the US.
This rising demand is expected to bolster the US IVD Contract Manufacturing Market as healthcare providers seek efficient and effective testing solutions.
Advancements in Technology and Automation
Technological advancements and automation in the manufacturing processes are critical drivers for the US IVD Contract Manufacturing Market. The integration of cutting-edge technologies such as artificial intelligence and machine learning in diagnostic manufacturing has shown to enhance production efficiency and accuracy.
Data from the National Institute of Standards and Technology indicates that automation can increase production efficiency by up to 30%, facilitating higher output with reduced human error.
Leading firms, including Thermo Fisher Scientific and Siemens Healthineers, are investing in automation, making significant strides in upgrading their manufacturing capabilities. This results in improved turnaround times and cost-effectiveness that greatly encourage more companies to outsource manufacturing to contract manufacturers in the US.
Emphasis on Regulatory Compliance and Quality Control
The increasing complexity of regulations surrounding in-vitro diagnostics (IVD) is fostering growth in the US IVD Contract Manufacturing Market, as original equipment manufacturers (OEMs) look to contract manufacturers to ensure compliance.
The US Food and Drug Administration (FDA) imposes strict guidelines that require adherence to the quality management system in manufacturing processes. Companies such as Becton Dickinson and Company are proactively engaging with contract manufacturers to adhere to these regulations, which has resulted in more stringent quality control measures in the production of diagnostic devices.
Emphasizing quality and compliance not only mitigates risks associated with regulatory failures but also positions these organizations as competitive in a pressing market, ultimately resulting in increased contract manufacturing referrals.
Growing Focus on Chronic Disease Management
The surge in chronic diseases such as diabetes, cardiovascular diseases, and cancers in the US is a significant driver within the US IVD Contract Manufacturing Market. According to the American Heart Association, over 48% of adults in the United States have some form of cardiovascular disease.
This mounting prevalence drives demand for diagnostic tests that are crucial for early detection and ongoing management of these illnesses. Entities like Abbott Laboratories and Medtronic are developing innovative diagnostic solutions, which pushes the need for specialized manufacturing capabilities.
Consequently, contract manufacturers are increasingly engaged to produce advanced diagnostic devices tailored for chronic disease management, creating a positive outlook for the market growth in the US.
US IVD Contract Manufacturing Market Segment Insights
IVD Contract Manufacturing Market Product Type Insights
The US IVD Contract Manufacturing Market encompasses various product types, each playing a crucial role in the overall landscape of diagnostic testing and medical technology. Among these, reagents are vital as they facilitate the biochemical reactions necessary for diagnostic processes, establishing their significance in the overall market.
They are commonly used in a wide range of tests, including infectious diseases, immunology, and genetics, thus driving significant demand and innovation in this field. Diagnostic devices, another key product type, include instruments and systems utilized to perform tests for the detection and diagnosis of diseases.
Their technological advancement, such as the integration of artificial intelligence and automation, is reshaping how diagnostics are conducted, leading to more accurate and quicker results, which are paramount in today's healthcare environment.
Assay kits, designed for specific testing needs, are integral to laboratories and clinics, enabling efficient and reliable analysis of samples. Their importance lies in the capacity to deliver precise results, which can lead to timely and effective treatment plans.
The growing need for personalized medicine and advancements in biotechnology further bolsters the demand for specialized assay kits in the market. Meanwhile, consumables play an essential role as they encompass various single-use items required during the testing process, ensuring the efficiency and cleanliness of diagnostic workflows.
The ongoing developments in manufacturing processes of consumables, driven by the need for scalable production and quality assurance, highlight their importance in supporting the healthcare sector. Overall, the intricate interplay between these product types within the US IVD Contract Manufacturing Market highlights the continuous growth and evolution of diagnostic solutions.
The combined demand from hospitals, laboratories, and research institutions is indicative of the dynamic nature of the market, fueled by technological innovations and the rising need for effective diagnostics. As the industry progresses, the emphasis on quality, reliability, and speed among these product types will remain a focal point to meet the increasing healthcare demands across the United States.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
IVD Contract Manufacturing Market Technology Insights
The Technology segment of the US IVD Contract Manufacturing Market plays a crucial role in the broader healthcare landscape, facilitating advancements in disease detection and monitoring. This segment encompasses various areas, including Molecular Diagnostics, Immunoassays, Clinical Chemistry, and Microbiology, which are essential for developing precise and timely diagnostic solutions.
Molecular Diagnostics is particularly significant as it leverages genetic and molecular information, driving innovations in personalized medicine and targeted therapies. Immunoassays dominate the market by offering rapid and accurate results for a range of diseases, significantly enhancing patient management.
Clinical Chemistry remains a cornerstone of routine laboratory testing, ensuring the availability of vital biochemical data that informs clinical decisions. Meanwhile, Microbiology serves a fundamental purpose in identifying infectious agents, which is essential for public health safety and effective treatment strategies.
This diverse Technology landscape contributes to the overall enhancement of diagnostic accuracy and accessibility, meeting the increasing demand for efficient and reliable testing solutions in the US.
Growth drivers in this space are bolstered by heightened awareness of preventive healthcare and significant investments in Research and Development, while challenges include regulatory hurdles and maintaining product quality.
IVD Contract Manufacturing Market End-user Insights
The End-user segment of the US IVD Contract Manufacturing Market encompasses a variety of key players, including Hospitals, Diagnostic Laboratories, Research Institutions, and Home Care settings. Hospitals are crucial as they often require continuous supply of in-vitro diagnostic products to ensure accurate patient care.
This segment is characterized by advanced technological infrastructure that demands high-quality manufacturing standards, making them a significant contributor to the overall market dynamics. Diagnostic Laboratories play a vital role, representing the core of testing services and often exhibiting a majority holding due to their need for diverse IVD solutions tailored for varied diseases.
Research Institutions are also integral, as they drive innovation and new product development, facilitating advancements in the diagnostic field which can lead to growth opportunities. In recent years, the Home Care segment has gained prominence, underscoring the trend toward at-home testing solutions, aligning with the growing consumer preference for convenience and remote health management.
Collectively, these segments reflect the diverse applications of IVD products, highlighting a dynamically evolving landscape driven by technological advancements and changing healthcare needs in the US.
IVD Contract Manufacturing Market Service Type Insights
The US IVD Contract Manufacturing Market focuses on various Service Type segments essential for producing in vitro diagnostic devices. Among these, Manufacturing Services encompass a wide range of processes, including assembly and quality control, which are critical for meeting strict regulatory standards in the US healthcare landscape.
Research and Development Services play a significant role by driving innovation and enhancing product efficacy through extensive testing and validation processes, aiding manufacturers in staying competitive. Packaging Services are crucial as they ensure product integrity, comply with regulatory requirements, and enhance marketability.
The growing demand for personalized medicine and increased prevalence of chronic diseases in the US are driving growth and investment in these service segments. Overall, the segmentation demonstrates an intricate interdependence among these services, with each contributing significantly to the overall efficiency, safety, and quality of IVD products in the market.
The engagement in technology advancements and focus on regulatory compliance are essential in maintaining market dynamics and addressing the challenges posed by ever-evolving healthcare demands.
US IVD Contract Manufacturing Market Key Players and Competitive Insights
The US IVD Contract Manufacturing Market has been experiencing dynamic changes, driven by advancements in technology, increasing demand for diagnostic tests, and a shift towards personalized medicine. The competitive landscape features numerous players who provide essential services from product development to regulatory compliance.
This sector is characterized by collaborations, joint ventures, and partnerships, as companies strive to enhance their capabilities and market reach. The growing prevalence of chronic diseases and a greater emphasis on preventive healthcare have further stimulated demand, creating opportunities for both established firms and new entrants.
The emergence of innovative diagnostic solutions and the push for rapid testing methods position this market at the forefront of healthcare strategy in the US.
Abbott Laboratories stands out in the US IVD Contract Manufacturing Market due to its vast expertise and solid brand reputation. The company leverages its extensive portfolio of diagnostic products, which include immunoassays, molecular diagnostics, and point-of-care testing solutions.
Abbott's strengths are exemplified by its robust research and development capabilities, allowing it to consistently introduce cutting-edge technologies that meet evolving healthcare needs. The company's established relationships with healthcare providers and its commitment to quality assurance further bolster its market presence.
By maintaining a strong focus on innovation and customer service, Abbott Laboratories reinforces its leadership position within the competitive frame of the US IVD sector, effectively addressing the increasing demand for efficient and reliable diagnostic solutions.
Thermo Fisher Scientific has a significant foothold in the US IVD Contract Manufacturing Market, recognized for its comprehensive array of laboratory and diagnostic solutions. The company specializes in various key products, including analyzers, reagents, and software services tailored for diagnostic applications.
With a focus on enhancing operational efficiencies and automating processes, Thermo Fisher fosters innovation in IVD manufacturing. Strengths such as extensive global reach, advanced technologies, and a wide service offering have positioned Thermo Fisher as a formidable player in the market.
The company's strategy involves strategic mergers and acquisitions to enhance its portfolio and expand market share. This proactive approach enables Thermo Fisher Scientific to stay ahead of the curve in a competitive landscape, ultimately driving growth and meeting the diverse needs of healthcare providers in the United States.
Key Companies in the US IVD Contract Manufacturing Market Include:
US IVD Contract Manufacturing Market Developments
The US IVD (In Vitro Diagnostic) Contract Manufacturing Market has recently seen significant developments. Notably, Abbott Laboratories and Danaher Corporation have reported substantial growth in their manufacturing capabilities, driven by rising demand for diagnostic testing amid ongoing public health challenges.
Siemens Healthineers launched a new production line to enhance its capacity for point-of-care testing, while Thermo Fisher Scientific has expanded its portfolio through strategic research initiatives. On the acquisition front, in March 2023, Roche Diagnostics announced the acquisition of a notable biosensor company to strengthen its market position, backed by consistent media coverage.
Additionally, Beckman Coulter has focused on increasing its automation in manufacturing to improve efficiency. The market has been buoyed by partnerships between IVD companies and technology providers to innovate new diagnostic solutions.
Major events in the last few years include the surge in testing requirements during the COVID-19 pandemic, leading to an uptick in manufacturing activities. Currently, the market shows positive valuation growth, driven by advancements in biotechnology and increasing healthcare investments, which support the continuous evolution of IVD contract manufacturing in the US.
US Ivd Contract Manufacturing Market Segmentation Insights
| Report Attribute/Metric | Details |
| Market Size 2023 | 1.74(USD Billion) |
| Market Size 2024 | 1.95(USD Billion) |
| Market Size 2035 | 3.49(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 5.411% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, PerkinElmer, Beckman Coulter, Chembio Diagnostics, BD, BioRad Laboratories, Hologic, Genomatica, Quest Diagnostics, Ortho Clinical Diagnostics, Medtronic, Roche Diagnostics |
| Segments Covered | Product Type, Technology, End-user, Service Type |
| Key Market Opportunities | Increased demand for personalized medicine, Growth in point-of-care testing, Advancements in automation technology, Rising focus on regulatory compliance, Expansion of home diagnostic testing |
| Key Market Dynamics | rising demand for personalized medicine, technological advancements in diagnostics, regulatory compliance challenges, cost efficiency in production, increasing outsourcing trends |
| Countries Covered | US |
Frequently Asked Questions (FAQ) :
The market size of the US IVD Contract Manufacturing Market in 2024 was valued at 1.95 billion USD.
By 2035, the US IVD Contract Manufacturing Market is projected to reach a value of about 3.49 billion USD.
The expected CAGR for the US IVD Contract Manufacturing Market from 2025 to 2035 is approximately 5.411%.
The major product segments expected to dominate include Reagents, Diagnostic Devices, Assay Kits, and Consumables.
In 2024, the market value for reagents in the US IVD Contract Manufacturing Market was expected to be around 0.55 billion USD.
The Diagnostic Devices segment is expected to be valued at approximately 1.2 billion USD by 2035.
Key players in the market include Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, and Danaher Corporation.
The US IVD Contract Manufacturing Market may face challenges such as regulatory hurdles and supply chain disruptions.
The market presents opportunities driven by advancements in diagnostic technologies and increasing demand for personalized medicine.
The Consumables segment is projected to be valued at around 0.49 billion USD in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
